Abstract

Midazolam 1 mg/mL in SyrSpend SF or SyrSpend SF Cherry

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2018 - Volume 22, Number 4

Page(s): 321

Download in electronic PDF format for $75

Abstract

A formulation for preparing Midazolam 1 mg/mL in SyrSpend SF or SyrSpend SF Cherry. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jul/Aug 2018 Pg. 321	Midazolam 1 mg/mL in SyrSpend SF or SyrSpend SF Cherry Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 344-346	Stability of Midazolam in SyrSpend SF and SyrSpend SF Cherry Author(s): Geiger Christine M, Sorenson Bridget, Whaley Paul A
Jan/Feb 2010 Pg. 82-85	Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution) Author(s): Voudrie Mark A II, Allen D Brett
Mar/Apr 2012 Pg. 162	Midazolam 5-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Mar/Apr 2022 Pg. 143	Lorazepam 1 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 146	Phenobarbital 10 mg/mL in SyrSpend SF pH4, Cherry Flavored Author(s): Allen Loyd V Jr
Sep/Oct 2006 Pg. 387	Midazolam Hydrochloride 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 420-427	Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF Author(s): Geiger Christine M, Sorenson Bridget, Whaley Paul
Jul/Aug 2021 Pg. 327	Nifedipine 4.mg/mL in SyrSpend SF pH4 Cherry Flavored Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 493	Ursodiol 30 mg/mL in SyrSpend SF Cherry Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 54	Amiodarone Hydrochloride 5 mg/mL in SyrSpend SF pH4 Cherry Flavored Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 140	Alprazolam 1 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 74-77	Stability of Midazolam Intranasal Formulation for the Treatment of Status Epilepticus in Dogs Author(s): Elder Deborah Lester, Zheng Bo, White Catherine A, Li Dawei
Nov/Dec 2004 Pg. 462-465	Basics of Compounding for Cough Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 240-241	Updated Stability Data for Midazolam, Oseltamivir Phosphate, and Propranolol Hydrochloride in SyrSpend SF and Minoxidil in Espumil Author(s): Dijkers Eli, Nanhekhan Valerie, Thorissen Astrid
Nov/Dec 2012 Pg. 510-512	Stability of Ursodiol in SyrSpend SF Cherry Flavored Author(s): Geiger Christine M, Voudrie Mark A II, Sorenson Bridget
Jul/Aug 2012 Pg. 347-349	Stability of Gabapentin in SyrSpend SF Author(s): Sorenson Bridget, Voudrie Mark A II, Gehrig Dan
May/Jun 2018 Pg. 233	Atenolol 1 mg/mL or 5 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 315	Hydrocortisone Hemisuccinate 2 mg/mL or Hydrocortisone Sodium Phosphate 2 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr